Future directions

Development of methods that allow immediate and safe removal of sulfur-containing gases is of the utmost priority. Direct desulfurization of the blood(1)of cancer patients and development of new compounds that can inactivate sulfur compounds are various new approaches being taken towards cancer therapy. Our laboratory has been working on the development of a new compound that can rapidly metabolize sulfur-containing gases. Our preliminary work has demonstrated a reduction in tumor size using this compound to remove internalized sulfur-containing gases (manuscript in preparation). If we can develop a highly efficacious drug that could be used in the clinic, a new cancer therapy that spares the body from heavy burden can be established, ultimately leading to prevention of metastasis and cancer relapse.



Generation of gaseous sulfur-containing compounds in tumour tissue, and suppression of gas diffusion as an anti-tumour treatment : K.Yamagishi, K.Onuma, Y.Chiba, et al.: doc10.1136/gutjnl-2011-300721.


McCulloch M, Jezierski T, Broffman M, et al. Diagnostic accuracy of canisescent
detection in early- and late-stage lung and breast cancers. Integr Cancer Ther 2006;5:30-9.


Sonoda H, Kohnoe S, Yamazato T, et al. Colorectal cancer screening with odour
materials by canines scent detection. Gut 2011;60:814-19.


Gordon T, Schatz B, Myers J, et al. Urinary volatile compounds as biomarkers for
lung cancer: a proof of principle study using odor signatures in mouse models of lung
cancer. J Altern Complement Med 2008;14:61-7.


Gut Online First, published on August 11, 2011 as 10.1136/gutjnl-2011-300721


JohnWiley& Sons,Inc.


Hadden JW. Immunodeficiency and cancer: prospects for correction. Int
Immunopharmacol 2003;3:1061e71.


Fischer K, Hoffman P, Voelkl S, et al. Inhibitory effect of tumor cell-derived lactic acid on human T cells. Blood 2007;109:3812e19.